002038.SZ
Price:
$6.73
Market Cap:
$6.90B
Beijing SL Pharmaceutical Co., Ltd., a biopharmaceutical company, researches, develops, produces, and markets genetic engineering and related drugs in the People's Republic of China and internationally. The company's finished formulations includes temozolomide; arsenic trioxide; lenalidomide; docetaxel; paclitaxel; filgrastim Recombinant human granulocyte colony-stimulating factor; recombinant human interleukin-11; recombinant human interleukin-2; thymopentin; vinorelbine bitartrate; hydroxyl-camptothecine; nimustine hydrochloride; asparaginase; PEG L-asparaginase; calcium foliate; recombinant human basic fibroblast growth factor; ciclosporin; mycophenolate mofetil dispersible; ornidazole; a...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2004-09-09
Stock Exchange
SHZ
Ticker
002038.SZ
According to Beijing SL Pharmaceutical Co., Ltd.’s latest financial reports and current stock price. The company's current PE Ratio is -67.30. This represents a change of 214.20% compared to the average of -21.42 of the last 4 quarters.
The mean historical PE Ratio of Beijing SL Pharmaceutical Co., Ltd. over the last ten years is 20.16. The current -67.30 PE Ratio has changed -33489.95% with respect to the historical average. Over the past ten years (40 quarters), 002038.SZ's PE Ratio was at its highest in in the September 2023 quarter at 7.87K. The PE Ratio was at its lowest in in the January 2023 quarter at -576.60.
Average
20.16
Median
28.40
Minimum
-106.71
Maximum
56.19
Discovering the peaks and valleys of Beijing SL Pharmaceutical Co., Ltd. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 53.37%
Maximum Annual PE Ratio = 56.19
Minimum Annual Increase = -529.37%
Minimum Annual PE Ratio = -106.71
Year | PE Ratio | Change |
---|---|---|
2024 | -106.71 | -529.37% |
2023 | 24.85 | -31.01% |
2022 | 36.03 | 38.17% |
2021 | 26.07 | -8.36% |
2020 | 28.45 | 1.69% |
2019 | 27.98 | -1.28% |
2018 | 28.34 | -49.56% |
2017 | 56.19 | 38.84% |
2016 | 40.47 | 1.44% |
2015 | 39.89 | 53.37% |
The current PE Ratio of Beijing SL Pharmaceutical Co., Ltd. (002038.SZ) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
-15.28
5-year avg
1.74
10-year avg
20.16
Beijing SL Pharmaceutical Co., Ltd.’s PE Ratio is less than Hualan Biological Engineering Inc. (26.04), less than Zhejiang NHU Company Ltd. (10.26), less than Yifan Pharmaceutical Co., Ltd. (32.94), less than Huadong Medicine Co., Ltd (19.96), less than Daan Gene Co., Ltd. (-15.88),
Company | PE Ratio | Market cap |
---|---|---|
26.04 | $29.95B | |
10.26 | $69.55B | |
32.94 | $15.19B | |
19.96 | $71.20B | |
-15.88 | $8.38B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Beijing SL Pharmaceutical Co., Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Beijing SL Pharmaceutical Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Beijing SL Pharmaceutical Co., Ltd.'s PE Ratio?
How is the PE Ratio calculated for Beijing SL Pharmaceutical Co., Ltd. (002038.SZ)?
What is the highest PE Ratio for Beijing SL Pharmaceutical Co., Ltd. (002038.SZ)?
What is the 3-year average PE Ratio for Beijing SL Pharmaceutical Co., Ltd. (002038.SZ)?
What is the 5-year average PE Ratio for Beijing SL Pharmaceutical Co., Ltd. (002038.SZ)?
How does the current PE Ratio for Beijing SL Pharmaceutical Co., Ltd. (002038.SZ) compare to its historical average?